Reproducibility and Comparison of DCE-MRI and DCE-CT Perfusion Parameters in a Rat Tumor Model
暂无分享,去创建一个
Wei Wei | Chaan S Ng | Vikas Kundra | Edward F Jackson | John C Waterton | V. Johnson | C. Ng | J. Waterton | E. Jackson | Wei Wei | V. Kundra | Valen E Johnson | Murali Ravoori | David Brammer | Lin Han | Sherry Klumpp | M. Ravoori | Lin Han | D. Brammer | S. Klumpp
[1] A. Padhani,et al. Reproducibility of dynamic contrast‐enhanced MRI in human muscle and tumours: comparison of quantitative and semi‐quantitative analysis , 2002, NMR in biomedicine.
[2] Benjamin M Yeh,et al. Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with advanced solid tumors: results from a phase I study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] Geoff J M Parker,et al. Imaging Tumor Vascular Heterogeneity and Angiogenesis using Dynamic Contrast-Enhanced Magnetic Resonance Imaging , 2007, Clinical Cancer Research.
[4] Rajesh Odedra,et al. Examining the acute effects of cediranib (RECENTIN, AZD2171) treatment in tumor models: a dynamic contrast-enhanced MRI study using gadopentate. , 2009, Magnetic resonance imaging.
[5] Weijing Sun,et al. Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Ricky T. Tong,et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer , 2004, Nature Medicine.
[7] Alan Jackson,et al. Dynamic contrast-enhanced magnetic resonance imaging in oncology , 2005 .
[8] Edward Ashton,et al. Dynamic Contrast-Enhanced Magnetic Resonance Imaging , 2012, Definitions.
[9] R. Craen,et al. Quantitative assessment of cerebral hemodynamics using CT: stability, accuracy, and precision studies in dogs. , 1999, Journal of computer assisted tomography.
[10] Joanna Leadbetter,et al. Magnetic Resonance Imaging Measurements of the Response of Murine and Human Tumors to the Vascular-Targeting Agent ZD6126 , 2004, Clinical Cancer Research.
[11] J. Waterton,et al. Effects of AZD2171 and vandetanib (ZD6474, Zactima) on haemodynamic variables in an SW620 human colon tumour model: an investigation using dynamic contrast‐enhanced MRI and the rapid clearance blood pool contrast agent, P792 (gadomelitol) , 2008, NMR in biomedicine.
[12] C. Ng,et al. Reproducibility of perfusion parameters in dynamic contrast-enhanced MRI of lung and liver tumors: effect on estimates of patient sample size in clinical trials and on individual patient responses. , 2010, AJR. American journal of roentgenology.
[13] C. Dick,et al. X-ray attenuation properties of radiographic contrast media. , 1987, Medical physics.
[14] Ting-Yim Lee. Functional CT: physiological models , 2002 .
[15] J R Griffiths,et al. Clinical studies. , 2005, Advances in pharmacology.
[16] M. Knopp,et al. Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.
[17] T. Purdie,et al. Functional CT imaging of angiogenesis in rabbit VX2 soft-tissue tumour. , 2001, Physics in medicine and biology.
[18] R. Herbst,et al. Tumor Blood Flow Measured by Perfusion Computed Tomography and 15O-Labeled Water Positron Emission Tomography: A Comparison Study , 2009, Journal of computer assisted tomography.
[19] J R Griffiths,et al. Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imaging , 2003, British Journal of Cancer.
[20] Edward F. Jackson,et al. A phase I surrogate endpoint study of SU6668 in patients with solid tumors , 2004, Investigational New Drugs.
[21] R. Craen,et al. A CT method to measure hemodynamics in brain tumors: validation and application of cerebral blood flow maps. , 2000, AJNR. American journal of neuroradiology.
[22] J. Waterton,et al. Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours , 2003, British Journal of Cancer.
[23] P. Tofts,et al. Accurate and precise measurement of blood-retinal barrier breakdown using dynamic Gd-DTPA MRI. , 1992, Investigative ophthalmology & visual science.
[24] R. Craen,et al. Dynamic CT measurement of cerebral blood flow: a validation study. , 1999, AJNR. American journal of neuroradiology.